Paper2230000
Spontaneous reactivation in chronic hepatitis B: patterns and natural history.
Gupta S and 3 others. J Clin Gastroenterol, 1990. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. Spontaneous reactivation in chronic hepatitis B: patterns and natural history. Papers, record 2230000. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2230000
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis B | Major topic |
| Hepatitis B virus | Major topic |
| Virus Activation | Major topic |
| Adult | |
| Aged | |
| Alanine Transaminase | |
| Bilirubin | |
| Chronic Disease | |
| DNA, Viral | |
| Follow-Up Studies | |
| Humans | |
| Immunoglobulin M | |
| Liver | |
| Male | |
| Middle Aged | |
| Recurrence | |
| Retrospective Studies | |
| Survival Rate |
Source PubMed
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40673674 | Anti-HBc IgM associates with acute flare and HBeAg/HBsAg loss in chronic hepatitis B patients with acute exacerbation. | Virulence | 2025 | https://conductscience.org/library/papers/40673674 | PubMed |
| 37736699 | Hepatitis B reactivation in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis. | Infect Dis Poverty | 2023 | https://conductscience.org/library/papers/37736699 | PubMed |
| 35430783 | KASL clinical practice guidelines for management of chronic hepatitis B. | Clin Mol Hepatol | 2022 | https://conductscience.org/library/papers/35430783 | PubMed |
| 34840146 | Risk of Hepatitis B Virus (HBV) Reactivation in Patients with Immune-Mediated Inflammatory Diseases Receiving Biologics: Focus on the Timing of Biologics after Anti-HBV Treatment. | Gut Liver | 2022 | https://conductscience.org/library/papers/34840146 | PubMed |
| 34621337 | COVID-19 Pandemic Impact on Cord Blood Collection for Stem Cell Use and Actual Perspectives. | Maedica (Bucur) | 2021 | https://conductscience.org/library/papers/34621337 | PubMed |
| 33708775 | Update in Viral Infections in the Intensive Care Unit. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/33708775 | PubMed |
| 33458253 | Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection. | Wellcome Open Res | 2020 | https://conductscience.org/library/papers/33458253 | PubMed |
| 33067316 | Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy. | J Immunother Cancer | 2020 | https://conductscience.org/library/papers/33067316 | PubMed |
| 32729014 | Comparison of Tenofovir Disoproxil Fumarate and Entecavir in the Prophylaxis of HBV Reactivation. | Dig Dis Sci | 2021 | https://conductscience.org/library/papers/32729014 | PubMed |
| 32188424 | Case reports of latent HBV hepatitis in patients after neurosurgical treatment for hypothalamic and pituitary tumors. | BMC Infect Dis | 2020 | https://conductscience.org/library/papers/32188424 | PubMed |
| 31257349 | DLBCL developed into fatal liver failure during rituximab-containing chemotherapy. | J Clin Exp Hematop | 2019 | https://conductscience.org/library/papers/31257349 | PubMed |
| 31185710 | KASL clinical practice guidelines for management of chronic hepatitis B. | Clin Mol Hepatol | 2019 | https://conductscience.org/library/papers/31185710 | PubMed |
| 30011286 | Vaccine uptake and immune responses to HBV infection amongst vaccinated and non-vaccinated healthcare workers, household and sexual contacts to chronically infected HBV individuals in the South West Region of Cameroon. | PLoS One | 2018 | https://conductscience.org/library/papers/30011286 | PubMed |
| 29663729 | Hepatitis B infection reported with cancer chemotherapy: analyzing the US FDA Adverse Event Reporting System. | Cancer Med | 2018 | https://conductscience.org/library/papers/29663729 | PubMed |
| 28158970 | Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy. | BMC Immunol | 2017 | https://conductscience.org/library/papers/28158970 | PubMed |
| 27628420 | Treatment of Hepatitis B: A Concise Review. | Clin Transl Gastroenterol | 2016 | https://conductscience.org/library/papers/27628420 | PubMed |
| 27044762 | KASL clinical practice guidelines: management of chronic hepatitis B. | Clin Mol Hepatol | 2016 | https://conductscience.org/library/papers/27044762 | PubMed |
| 26739135 | Prevention and management of hepatitis B virus reactivation in cancer patients. | Hepatol Int | 2016 | https://conductscience.org/library/papers/26739135 | PubMed |
| 26581426 | Acute hepatitis B virus infection or acute exacerbation of chronic hepatitis B infection: the differential serological diagnosis. | Eur J Clin Microbiol Infect Dis | 2016 | https://conductscience.org/library/papers/26581426 | PubMed |
| 26563120 | Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. | Hepatol Int | 2016 | https://conductscience.org/library/papers/26563120 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2230000
GET https://conductscience.org/api/papers/v1/2230000/cited_by?page=2